What Happens When You Stop GLP-1: The Honest, Evidence-Based Answer
By GLP-1 Evolution Research Team | Last updated: May 18, 2026
TL;DR
- STEP-4 trial: patients who stopped semaglutide at week 20 regained about two-thirds of their weight loss by week 68.
- Appetite typically returns within 2-4 weeks of the last dose.
- GLP-1s are not addictive; there's no classic withdrawal syndrome.
- Most clinicians now treat GLP-1s as long-term therapy similar to blood pressure medication.
- If cost is the reason for stopping, switch to compounded ($129-$249/month) before quitting entirely.
The Question Patients Ask First and Loudest
"What happens when I stop?" is usually the second question after "How much will I lose?" The answer matters because it changes the cost-benefit math: if you can take a GLP-1 for 12 months and keep the loss, that's a different financial decision than a lifetime medication. The evidence-based answer is the latter — substantial regain is typical, and the medication is increasingly framed as long-term therapy.
The Evidence: STEP-4 and Beyond
The STEP-4 trial (Rubino et al., JAMA 2021) is the cleanest data we have on stopping semaglutide. Patients ran on semaglutide 2.4 mg weekly for 20 weeks (open-label dose escalation), then were randomized either to continue semaglutide or to switch to placebo. By week 68:
- Continued semaglutide group: additional ~7.9% weight loss on top of the 10.6% lost during open-label.
- Switched to placebo group: regained about 6.9% of the body weight they had lost.
The bigger SELECT cardiovascular outcomes data tells the same story: weight loss is maintained on continued therapy, attenuates when therapy stops. SURMOUNT-4 extension data for tirzepatide showed similar patterns of regain after withdrawal.
Why the Body Regains
Obesity is increasingly understood as a chronic, relapsing condition driven by appetite, satiety signaling, and the brain's defended weight setpoint. GLP-1 medications modify those mechanisms while the drug is in circulation. They don't permanently reset the system. When the drug clears, your pre-treatment appetite and setpoint resume. Without the satiety augmentation, you eat more — often without realizing it — and the weight comes back.
Hormonal counter-regulation is also at play. Leptin, ghrelin, and other appetite hormones shift in response to weight loss, and those shifts persist after weight loss. The body is biologically primed to defend its prior weight.
What This Means in Practice
The implication isn't "don't try GLP-1." The implication is "plan for long-term therapy, not a 12-week protocol." Treating GLP-1s as you'd treat statins or antihypertensives — chronic medications for chronic conditions — yields the best outcomes.
That said, there are situations where stopping or pausing makes sense:
- Pregnancy or planning pregnancy.
- Severe side effects that don't resolve with dose adjustment.
- Cost becoming unsustainable (in which case, see below).
- Specific medical contraindication emerging.
If Cost Is the Reason
The most common reason people stop GLP-1s is cost. If branded Wegovy or Zepbound at $1,000-$1,400/month has become unsustainable, the first move is to switch to compounded — not to stop entirely. Compounded semaglutide via vetted US telehealth: $129-$249/month. Same molecule, dramatically lower cost.
Our entry-tier pick: Embody at $149/month. For flat-rate predictability: Eden Health at $209/month. Both are dramatically cheaper than stopping and regaining.
How to Taper (If You're Going to Stop)
If your prescriber agrees stopping is appropriate, tapering may smooth the transition:
- Step down dose levels over 8-12 weeks rather than abruptly stopping at therapeutic dose.
- Extend the interval — go from weekly to every-10-days, then to every-2-weeks, before stopping.
- Maintain protein and resistance training. The post-stop window is when lean mass losses can compound.
- Track weight weekly. Catch regain early; consider restarting at the lowest dose if it accelerates.
Cold-turkey stopping is also acceptable — the medication doesn't cause withdrawal — but the appetite rebound is sharper.
What You Can Do to Reduce Regain
No protocol prevents all regain after stopping, but aggressive lifestyle interventions help:
- Continue 1.2-1.6 g/kg protein daily.
- Maintain resistance training 2-3x weekly (protects lean mass and metabolic rate).
- Add cardio for total energy expenditure if you weren't doing it.
- Track food intake — without GLP-1 satiety augmentation, your perception of fullness will be less reliable.
- Consider lower-dose maintenance (e.g., 0.5-1.0 mg semaglutide weekly) instead of stopping entirely.
The Maintenance Dose Conversation
An increasingly common pattern: rather than stopping, patients drop to a lower maintenance dose once they've reached weight goals. The drug stays active enough to help defend the new weight without the side-effect intensity of the highest doses. Discuss this option with your prescriber rather than going to zero.
Frequently Asked Questions
Will I gain weight back?
Most patients regain ~two-thirds within a year per STEP-4.
How fast does appetite return?
Within 2-4 weeks of the last dose.
Taper or cold turkey?
Both are acceptable; tapering may smooth the rebound.
Short-term use?
Possible but expect significant regain.
Can't afford it?
Switch to compounded ($129-$249/month) before stopping entirely.
Withdrawal symptoms?
No — GLP-1s aren't addictive and don't cause classic withdrawal.
Why does weight come back so fast?
Underlying appetite, satiety, and setpoint biology resume when the drug clears.